pleural mesothelioma

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instance_of gptkb:Oncology
gptkbp:affects pleura
gptkbp:associated_with gptkb:Oncology
fibrosis
pleural effusion
gptkbp:caused_by asbestos exposure
gptkbp:clinical_trial ongoing
completed
gptkbp:death low
gptkbp:diagnosis biopsy
poor
imaging tests
typically 60s to 70s
gptkbp:financial_support gptkb:financial_assistance
gptkb:educational_resources
counseling services
palliative care
support groups
gptkbp:genetic_studies CDKN2 A deletion
BAP1 mutation
NF2 mutation
gptkbp:geographic_distribution higher in developed countries
higher in industrial areas
https://www.w3.org/2000/01/rdf-schema#label pleural mesothelioma
gptkbp:legal_issue compensation claims
asbestos litigation
gptkbp:number_of_stages stage I
stage IV
stage II
stage III
gptkbp:occurs_in rare
gptkbp:public_awareness gptkb:Mesothelioma_Awareness_Day
Asbestos Awareness Month
gptkbp:research_focus biomarkers
early detection
treatment options
gptkbp:risk_factor age
smoking
gender
gptkbp:symptoms chest pain
persistent cough
shortness of breath
gptkbp:treatment gptkb:surgery
variable
radiation therapy
chemotherapy
depends on stage
depends on patient health
depends on tumor location
depends on treatment type
gptkbp:type malignant
primary
gptkbp:bfsParent gptkb:malignant_mesothelioma
gptkbp:bfsLayer 7